The NF-κB p50 subunit is an important regulator of inflammation, with recent experimental evidence to support it also having a tumor suppressor role. Classically, p50 functions in heterodimeric form with the RelA (p65) NF-κB subunit to activate inflammatory genes.
Introduction
NF-κB is a family of five transcription factors (RelA (p65), RelB, c-Rel, p100/p52 p105/p50), that combine to control expression of hundreds of genes that impact on the regulation of cell proliferation and survival, differentiation, inflammation, metabolism, tissue repair and regeneration, fibrosis and cancer [1] . The most well-known and functionally characterized form of NF-κB is the so-called canonical RelA:p50 heterodimer that is activated in response to a variety of extracellular inflammatory stimuli (e.g. TNF, IL-1 and LPS). RelA:p50 is required for mounting inflammatory responses through RelA-mediated transcriptional activation of key cytokine and chemokine genes. Given the potential for inflammation to cause tissue damage, the activities of RelA are tightly regulated by a variety of inhibitory checkpoints and negative feedback mechanisms [2] . A major focus for our laboratory has been the functions of the p50 NF-κB subunit expressed from the NFKB1 gene and in particular its distinct role when operating without RelA as a dimer partner [3] . Expression of p50 is found in most cell types under resting conditions, however the subunit can be induced to higher levels of expression in response to inflammatory stimuli [4] . Although p50 is generated directly from NFKB1 transcripts [5] , a predominant source in inflammatory states is via processing of its p105 precursor. This processing involves signal-induced, ubiquitin-dependent limited proteolysis regulated by the KPC1 ubiquitin E3 ligase [6] . An important structural feature of p50 is its lack of the transactivation domain typically found in the Rel proteins, as such it relies upon its Rel dimerization partners (RelA, c-Rel and RelB) to induce gene expression. Importantly, p50 can also form homodimers, their assembly being under distinct post-translational control with evidence for the requirement of specific serine residues (e.g. Ser-65, Ser-337 and Ser-340) which appear to be non-essential for heterodimerisation [3, 7] . These observations raise the potential for selective modulation of NF-κB activities that are under the control of p50:p50 dimers.
In striking contrast to embryonic lethality found in rela -/-mice, the absence of p50 in nfkb1 -/-mice results in loss of immune tolerance, heightened inflammatory responses to tissue damage and spontaneous inflammatory-driven ageing, these phenotypes collectively indicating that p50
exerts important anti-inflammatory control in tissues [8] . We recently confirmed by a genetic approach that these anti-inflammatory effects are a consequence of activities of the p50:p50
homodimer. Mice genetically engineered to be selectively incapable of the assembly of homodimers phenocopied many of the pro-inflammatory features of nfkb1 -/-mice [3] . The precise mechanism by which homodimers suppress inflammation remains poorly defined, but may involve direct competition with Rel-containing dimers for occupancy of κB DNA binding motifs or a more active process in which recruitment of histone deacetylases promotes local chromatin remodeling into a repressed state [9] . In both cases, the interaction of the homodimer with co-repressors is an important regulatory feature. Bcl3 is an IκB-like protein that has been reported to directly physically combine with p50:p50 dimers to prevent ubiquitin-mediated degradation and thereby enhances the stability of homodimers bound at κB DNA binding motifs [10] . HDAC1 is a class I nuclear histone deacetylase that is also proposed to physically complex with p50 homodimers and to mediate repressive histone deacetylation of local chromatin at NF-κB-regulated genes. It is additionally suggested that CCAAT enhancer-binding proteins (C/EBP) may selectively remove HDAC1 from homodimers resulting in release of a subset of NF-κB target genes from transcriptional repression [11] . However, the precise nature of the interaction of the HDACs with p50 is poorly defined and the degree to which HDAC:p50 interactions contribute to the control of transcription is unclear.
Here, we define a specific site of interaction of HDAC1 on the p50 protein and report that mutation of this HDAC1 binding motif results in modulation of histone acetylation at a subset of NF-κB target genes and is associated with elevated chemokine expression and enhanced neutrophil chemotaxis. These discoveries significantly advance our understanding of a transcriptional repression mechanism that acts as a physiologically important constraint on NF-κB-dependent inflammation.
Materials and Methods

Cell Culture
Cos-7, U2OS, HELA and nfkb1 -/-Murine Embryonic Fibroblasts (MEFs) were maintained in DMEM (GIBCO) supplemented with 100 U/ml penicillin, 100μg/ml streptomycin, 2mM
L-glutamine and 10% fetal bovine serum at 37°C at an atmosphere of 5% CO2
Generation of Mutant p50-FLAG Constructs
Mutant constructs were all generated from a parent p50-FLAG pcDNA3.1 backbone kindly provided by N. D. Perkins (Newcastle University). Mutations were generated using a Q5 
Immunofluorescence Microscopy
U2OS cells were seeded at 40-50% confluency in 4 well chamber slides and transfected with 250ng/ml of either WT p50-FLAG, p50 Mu -FLAG or vehicle only and incubated for 24 hours.
Cells were then washed with PBS and fixed in 4% formaldehyde followed by permeabilization with 0.1% Triton-X and blocked for 1 hour in 5% Bovine Serum Albumin(BSA). Cells were then incubated over night at 4° with anti-FLAG-FITC antibody (F4049, Sigma) in 5% BSA.
Cells were then washed in PBS and mounted with ProLong Gold Antifade Mountant with DAPI (P36935, Thermo-Fisher) and imaged on a Nikon upright Confocal Microscope at x200.
Enzyme Linked Immunosorbent Assay
Enzyme Linked Immunosorbent Assay Mouse IL-6 DuoSet (DY406, R&D Systems) was used to quantify total mouse IL-6 in supernatant of nfkb1 -/-MEFs transfected with Vehicle, WT or p50 Mu for 18 hours followed by treatment with or without TNFα (10ng/ml) for 6 hours. This sandwich ELISA was performed as per manufacture instruction.
Chromatin Immunoprecipitation (ChIP)
Briefly, nfkb1 
RNA Isolation and Quantitative Real Time PCR
Total RNA was isolated from cells using an RNeasy Mini Kit (74104, Qiagen) and treated with DNAse. This RNA was then used as a template for the synthesis of complementary DNA using random primers (Promega). SYBR Green quantitative RT-PCR was performed using primers listed in Table 1 .
Neutrophil Isolation and Chemotaxis Assay
Bone marrow derived neutrophils were isolated from the femur and tibia of C57BL TNFα. After 2 hours neutrophils that migrated into the lower chamber were stained with trypan blue and counted by hemocytometer. Chemotaxis was performed in triplicate with n=3 conditioned media.
p50 Peptide and Substitution Array
p50 peptide and alanine substitution arrays were kindly provided by the Kiely Lab and were generated as previously described [12] . Membranes were blocked in 5% TBS-T for one hour followed by incubation with anti (1:5000) 6x-His Tag Monoclonal Antibody HRP (R931-25, Invitrogen) for 2 hours at room temperature and developed by chemiluminescence (Amersham Biosciences) to assess peptide antibody cross reactivity. 6xHis tagged recombinant HDAC1 (14-838, Millipore) at 5μg/ml in 1% milk TBS-T was then added over night at 4°C followed by TBS-T wash and incubation again with antibody and detection as described. This procedure was also performed on the p50 alanine substitution array. Images are representative of two independent arrays.
GRAMM-X Protein Interaction Prediction and Visualization
p50 HDAC1 interaction predictions were performed by the GRAMM-X software for ridged body protein-protein interactions. Chain A and B of the available crystal structure of the p50 homodimer (PDB ID:1NFK [13] ) were used as a receptor molecule for its ligand, chain B of the HDAC1 crystal structure (PDB ID:4BKX [14] ). Potential interacting intermolecular hydrogen bonds were calculated using the HBond function in UCSC Chimera with relaxed bond constraints of 7Å and 20% bond angle flexibility. Structural modelling and images were generated in UCSC Chimera [15] .
Transfection Efficiency
-/-MEF's were seeded in 4 well chamber slides and transfected with 200ng/ml pcDNA3 GFP and imaged after 24 hours at x100 magnification. pcDNA3 EGFP was a gift from Doug Golenbock (Addgene plasmid # 13031).
Statistical Analysis
Data are expressed as mean ± S.E.M. Microsoft Excel was used to perform unpaired Students ttest and one way A.N.O.V.A.s and *P<0.05, **P<0.01 or ***P<0.001 was considered significant.
Results and Discussion
p50 Interacts with HDAC1 in primary and transformed cells.
Previous in vitro biochemical investigations in mouse leukemia cell lines demonstrated potential for a p50:HDAC1 interaction [16] . However, as it has yet to be demonstrated in vivo, we established co-immunoprecipitation (CoIP) assays to detect p50:HDAC1 interactions from primary cells. As shown in Fig 1A, under resting conditions in mouse liver tissue we were able to CoIP HDAC1 with an anti-p50/p105 antibody indicating an interaction does occur between the two proteins in primary tissue. We also confirmed detection of the interaction in human Hela cells and demonstrated that stimulation with TNFα led to reduced CoIP of HDAC1 (Supp. 1A).
We conclude that a p50:HDAC1 complex can be detected in primary and cell lines and may be modulated in response to inflammatory stimuli, the latter in keeping with a model in which stimulated release of HDAC1 from p50 may serve to relieve HDAC1-mediated transcriptional repression at NF-κB target genes [11] . It should be noted this suggests that TNFα does not disrupt the p50:HDAC1 interaction directly, however, it is thought that it may allow the release of p65 and shifts the composition of dimers from a repressive p50:p50:HDAC1 complex to that of a p65:p50 heterodimer which can then recruit co-factors including histone acetyl transferases, to upregulate gene transcription.
We next employed in silico modelling to determine potential sites of interaction of HDAC1 on the p50 protein in the context of the structure determined from its DNA-bound homodimer form.
Using the GRAMM-X server for rigid body interactions we determined the highest scoring possible orientations for predicted binding of HDAC1, taking into account molecular symmetry and potential DNA clashes (Supp. 1B) [17] . This analysis identified two physically distinct sites of predicted HDAC1 interaction on p50 that are shown in Fig 1B. An important caveat of this analysis is that calculations were restricted by the incomplete resolved crystal structure of both proteins (p50 PDB: 1NFK [13] , HDAC1 PDB: 4BKX [14] ). However, this prediction still provides valuable information as it pertains to the broad regions of affinity between the two molecules and their suitability for direct interaction. To biochemically test this in silico data, we employed an array of 18 amino acid long peptides that overlap and span the full length of p50 to determine regions of the protein with the potential to directly bind to recombinant HDAC1.
Peptides shown under UV (Supp. 1C) were first probed for non-specific binding using detection antibody (Supp. D) before being incubated with and probed for HDAC1 binding. Four major regions of interaction were revealed and are identified by distinct color shading in the primary sequence format in Fig 1C and in a structural format in Fig 1D. Importantly, these peptide interactions confirmed the two predicted interaction sites on p50 determined by the in silico analysis. We therefore conclude that HDAC1 may complex with p50 via physical interactions at two distinct regions of the NF-κB subunit. One of these two sites, located at the far c-terminal region of p50 (shaded in yellow) particularly attracted our attention as it showed consistent binding with HDAC1 across multiple peptides (Fig 1C) , matched the highest scoring for interaction in the in silico analysis and has previously been reported as a site of interaction of p50 with IκBα and Bcl3 [18, 19] . Additionally, the other potential site (blue) highlighted residues with poorer accessibility which reside near the DNA binding domain of p50. 
A. Western Blot analysis of an endogenous co-immunoprecipitation showing HDAC1 precipitates in complex with p50 in untreated three-month-old WT whole liver extracts. Detection antibody produces a lower molecular weight nonspecific band in whole mouse tissue. Representative image of three independent experiments. (IP antibody: anti-p105/p50 (D7H5M CST), Detection antibodies: anti p50-HRP [ab195854 Abcam] anti-HDAC1-HRP conjugate [ab193096 Abcam]. B. Predicted association of HDAC1 [Yellow & Blue, PDB ID: 4BKX] with a p50 homodimer [Orange, PDB ID: 1NFK] depicting two potential sites of interaction as solved by the GRAMM-X software for ridged body protein docking. C. Peptide array of 120 sequential peptides of 18 amino acids spanning the length of p50 probed with recombinant HDAC1-Hisx3 highlighting multiple sights of potential interaction (n=2 (anti-6x-His Tag Monoclonal Antibody HRP, R931-25, Invitrogen). D. All regions of potential interaction discovered in the peptide array mapped to the crystal structure of the p50 homodimer.
HDAC1 interacts with p50 at its nuclear localization signal.
To better define the c-terminal binding site we employed scanning alanine substitutions into the peptides derived from this region that were previously shown to directly bind to recombinant HDAC1 and asked how these mutations affected the interaction. Fig 2A shows the resulting raw data which was used to locate an 7 amino acid long motif VQRKRQK (aa's 359-365 of Human p50) which showed differential binding. Fig 2B illustrated the degree to which each residue contributes to this apparent loss of binding specifically in peptide 120. When mutated to alanine, residues in this motif reduce the ability of recombinant HDAC1 to bind with peptides as it had bound previously. On inspection we realized that the VQRKRQK motif lies within the p50 nuclear localization signal (NLS) sequence at the far c-terminal of p50 and that this region is absent from the published protein crystal structure (Fig 2C) . To validate that this motif is required for HDAC1:p50 binding in vivo we employed site-directed mutagenesis to generate a series of mutant c-terminal FLAG-tagged p50 cDNA expression constructs carrying one or more amino acid switches to alanine within the VQRKRQK region. WT and mutant p50-FLAG cDNAs together with an HA-tagged HDAC1 cDNA were co-transfected into Cos-7 cells to determine effects of combinations of VQRKRQK mutations on the interaction (Fig 2D) .
Intriguingly, sequential mutations of the V359, R361 and K362 residues up to R363 resulted in an apparent increase in HDAC1 interaction as determined by Co-IP, however a construct (p50 Mu ) that combines these sequential mutations with mutation of K365 resulted in an almost complete loss of HDAC1:p50 binding in the Co-IP (Fig 2D) . Since independent mutation of K365 was insufficient to disrupt the HDAC1:p50 interaction (Supp. 2A), we conclude that multiple amino acid contacts are required for association with the VQRKRQK motif. Transfection of WT p50-FLAG and p50 Mu -FLAG constructs into human HeLa cells confirmed the ability of p50-FLAG to Co-IP endogenous HDAC1 and this experiment also validated in nfkb1 -/-MEFs (Supp. 2B) that disruption of the VQRKRQK motif in p50 Mu prevents the HDAC1 interaction (Fig 2E) .
Taken together these data provide evidence for sequence specificity of interaction of HDAC1
with the c-terminal end of p50 and suggest that multiple amino acids within the previously identified NLS are required to form a p50:HDAC1 complex. The p50 NLS is proposed to have a helical-like structure but with a high degree of flexibility that may enable interaction with several distinct molecular targets such as members of the IκB family as well as the nuclear importin receptors [20] .
Figure 2. HDAC1 interaction is mediated by residues near the p50 nuclear localization sequence
A. Alanine substitution peptide array of the terminal seven 18aa peptides probed with recombinant HDAC1 displaying differential binding based on specific amino acid changes (anti-6x-His Tag Monoclonal Antibody HRP, R931-25, Invitrogen). B. Representation listing all of the specific amino acids mutated to alanine within each peptide C. Residues which attenuate the interaction between HDAC1 and p50 peptides in context of the full-length protein D. Western blot analysis of a FLAG immunoprecipitation assay of indicated mutant p50 expressed in Cos7 cells transiently transfected along with HDAC1-HA. Complete mutation of the indicated residues (Sequence 4) result in a near total ablation of the p50:HDAC1 interaction in full length transiently transfected proteins (anti p50-HRP [ab195854 Abcam] anti-HDAC1-HRP conjugate [ab193096 Abcam]). E. Western blot analysis of a FLAG coimmunoprecipitation assay of HELA cells transiently transfected with WT or p50Mu mutant confirming loss interaction with endogenous HDAC1 under resting conditions. Representative image of three independent experiments. Antibodies are those used in panel D.
Fundamental functions of p50 are unaffected by loss of the HDAC1 interaction motif.
We were next interested in determining the functional impacts of p50 mutations that perturb HDAC1 binding. As shown in Fig 3A, binding of p65 and IκBɑ was unaffected by mutations in the p50 Mu protein in U20S cells. Similarly there was no effect of mutation of the VQRKRQK motif on the IκBα interaction in nfkb1 -/-murine embryonic fibroblasts (Fig 3B) , although we cannot rule out that pull down of IκBα occurred due to interaction with p65 in a p50 Mu :p65:IκBα complex. We also observed no differences in the ability of WT p50 and p50 Mu proteins to stimulate NF-κB-dependent transcription from co-transfected synthetic (3X κB-Luc) and natural (IκBα-Luc) promoters (Fig 3C) . Hence, p50 Mu retains the ability to assemble p65:p50 heterodimers and to support classical canonical NF-κB signaling under the regulation of IκBα.
Perhaps more unexpected was the lack of effect of the VQRKRQK mutations on nuclear expression of p50 Mu , verified by Western blotting in nfkb1 -/-MEFs and U20S cells (Fig 3D and Supp. 3A and B) and immunofluorescent localization (Fig 3E and Supp. 3C ). Moreover, this nuclear localization occurs in both resting and TNFɑ stimulated MEF's independent of expressed protein concentration (Supp. 2C). Additionally, ChIP assays on exogenously expressed FLAGtagged proteins suggested that VQRKRQK mutations displayed slight but non-significant reduction of binding of p50 with well-known target promoters cxcl1 and cxcl2, again confirming the presence of p50 Mu in the nucleus of transformed cells (Fig 3F) . These data therefore argue against an essential role of the NLS for p50 nuclear translocation and while being inconsistent with the original report that suggested an absolute requirement of the NLS, these data are in agreement with more recent published studies that experimentally demonstrate the NLS is probably non-essential for nuclear localization [10, 21] . However, we did note that our immunofluorescence images suggested higher cytoplasmic expression for p50 Mu compared with WT ( Figure 3E ). This observation may indicate that the NLS influences the efficiency of nuclear translocation. A caveat to this suggestion is an apparent technical difference between the Western blotting and immunofluorescence for detection of cytoplasmic p50, with the former we were able to detect similar abundant levels of cytoplasmic WT and mutant p50 proteins while with the latter we failed to observe WT p50 in the cytoplasm. Since our controls for nuclear contamination of cytoplasmic protein extracts were clean we are confident that the Western blot is detecting cytoplasmic p50. A possible explanation for the differences between the protocols is that in the native state of the immunofluorescence experiments, the FLAG epitope may be somehow masked in the cytoplasm. Further, since the FLAG tag is fused to the c-terminal end of p50, mutations in this region in the p50 Mu protein may have unmasked the FLAG epitope and explain why the mutant and not WT is detected. Despite these technical caveats, collectively the data show that the mutations in the NLS aimed at disruption of HDAC1 binding do not have a major impact on fundamental functions of p50 including its nuclear translocation or its ability to interact with target κB DNA binding sites. 
HDAC1:p50 regulates chromatin remodeling at neutrophil chemokine genes.
Having established that disruption of the HDAC1 interaction motif did not affect p50 binding to κB sites in the Cxcl1 and Cxcl2 genes we next determined if there was an effect on local chromatin structure in the promoter regions of these genes. To this end, we performed ChIP assays using a pan-acetylated lysine Histone 3 (Ac-H3) antibody on chromatin isolated from
nfkb1
-/-MEFs expressing either WT p50-FLAG or p50 Mu -FLAG proteins (Supp. 4A). As shown in Fig 4A, and Cxcl2 revealed that TNFα stimulation was higher for both transcripts in the presence of p50 Mu (Fig 4C) . In addition, following TNFα stimulation transcripts for Il-6, Cxcl10 and Mmp13
were also increased to a greater degree in the p50 Mu transfected MEFs (Fig 4C) . Moreover, ELISA for IL-6 in culture media confirmed that p50 Mu transfected cells secreted higher levels of the cytokine in comparison to the WT transfectants (Fig 4D) . Cells used in these experiments displayed a transfection efficacy of 73.7% (Supp. 4B). Finally, neutrophil migration assays revealed that conditioned media from TNF-stimulated p50 Mu expressing cells (Supp. 4C) resulted in enhanced neutrophil chemotaxis compared with media from cells expressing WT p50 (Fig 5) . We conclude that the p50-HDAC1 interaction restricts neutrophil chemoattraction under conditions of inflammatory stimulation. 
Conclusion
In summary, we present combined in silico, in vitro and in vivo data that supports a hypothesis that direct interaction of HDAC1 with p50 homodimers bound at κB sites of promoters and enhancers constitutes a key mechanism constricting NF-κB-dependent transcription of at least a subset of inflammatory genes. The NLS is now emerging as an important nexus for interaction of p50 with a number of different regulatory proteins; HDAC1 now joining Bcl3 and IκBα as identified NLS interacting factors. It is yet to be determined if these interactions are mutually exclusive. Bcl3 and HDAC1 seem to share at least the VQRKRQK motif which is required for each factor to complex with p50 but whether or not these are exclusive binding events warrants further investigation. As Bcl3 and HDAC1 provide distinct mechanisms through which p50 negatively controls gene expression, they may provide context-specific regulation that is determined by cell type, distinct κB promoter/enhancer sequences, the nature of inflammatory signaling, influences of adjacent transcription factors or of other cofactors required for assembly of Bcl3 and HDAC1 repression complexes. As we observed an enrichment of lysine acetylation at Cxcl1 and Cxcl2 promoters when they were associated with p50
Mu we suggest that this reflects disruption of an HDAC-mediated rather than Bcl3-regulated activity. As such, we propose that the controlled assembly of HDAC:p50:p50 complexes at neutrophil chemokine genes is a physiological requirement for effective control of neutrophilic inflammation. Table 2 Table of DNA plasmid constructs and the amounts used in the indicated application.
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